Share on LinkedInShare on LinkedIn

ARTICLE · 30 JUNE 2025

Market Intelligence Thought Leadership Award Winner

Life Sciences Outlook 2025 - Environment, Construction And Real Estate

The pathway to developing and operating pharmaceutical infrastructure in Ireland is complex. Planning permission granted by the planning authority or An Bord Pleanála ("ABP") and licences issued...

IrelandReal Estate and Construction

Key Points

  • The pathway to developing and operating pharmaceutical infrastructure in Ireland is complex. Planning permission granted by the planning authority or An Bord Pleanála ("ABP") and licences issued by the Environmental Protection Agency (the "EPA") are required to build and operate these developments. Currently there are significant delays in planning decisions being issued by ABP as well as EPA licences.
  • In addition, we are seeing an increasing number of legal challenges to these grants. The ever-changing European environmental legal landscape also presents additional challenges for developers preparing and submitting consenting applications and the decision makers deciding on the applications.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

This article contains a general summary of developments and is not a complete or definitive statement of the law. Specific legal advice should be obtained where appropriate.

See more popular content from